ECSP045099A - BIOLOGICAL PRODUCTS - Google Patents
BIOLOGICAL PRODUCTSInfo
- Publication number
- ECSP045099A ECSP045099A ECSP045099A ECSP045099A EC SP045099 A ECSP045099 A EC SP045099A EC SP045099 A ECSP045099 A EC SP045099A EC SP045099 A ECSP045099 A EC SP045099A
- Authority
- EC
- Ecuador
- Prior art keywords
- antibody molecule
- rdq
- fcve
- relates
- present
- Prior art date
Links
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000058223 human VEGFA Human genes 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a una molécula de anticuerpo que tiene especificidad para determinantes antigénicos del receptor que contiene el dominio insertado de quinasa humana (RDQ). La molécula de anticuerpo se une al RDQ con mayor afinidad que con el factor de crecimiento endotelial vascular humano FCVE, y previene la interacción entre FCVE y RDQ. La presente invención también se refiere a los usos terapéuticos de la molécula de anticuerpo y a los métodos para producir la molécula de anticuerpo.The present invention relates to an antibody molecule that has specificity for antigenic determinants of the receptor that contains the human kinase inserted domain (RDQ). The antibody molecule binds to the RDQ with greater affinity than with the human vascular endothelial growth factor FCVE, and prevents the interaction between FCVE and RDQ. The present invention also relates to the therapeutic uses of the antibody molecule and the methods of producing the antibody molecule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP045099 ECSP045099A (en) | 2004-05-07 | 2004-05-07 | BIOLOGICAL PRODUCTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP045099 ECSP045099A (en) | 2004-05-07 | 2004-05-07 | BIOLOGICAL PRODUCTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP045099A true ECSP045099A (en) | 2004-06-28 |
Family
ID=40435101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP045099 ECSP045099A (en) | 2004-05-07 | 2004-05-07 | BIOLOGICAL PRODUCTS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP045099A (en) |
-
2004
- 2004-05-07 EC ECSP045099 patent/ECSP045099A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121431T1 (en) | ANTIBODY MOLECULES SPECIFIC TO HUMAN OX40 | |
| AR051484A1 (en) | ANTIBODY MOLECULES THAT HAVE SPECIFICITY FOR IL - 17 HUMAN | |
| ECSP056014A (en) | ANTIBODY MOLECULES THAT HAVE SPECIFICITY FOR HUMAN IL-1ß | |
| CY1122073T1 (en) | ANTIBODY MOLECULES SPECIFIC FOR HUMAN OX40 | |
| CY1116488T1 (en) | ANTI-PERPETIN antibodies | |
| CY1121672T1 (en) | ANTIBODIES THAT BIND IL-17A AND IL-17F | |
| ECSP088613A (en) | ANTIBODY MOLECULES THAT HAVE SPECIFICITY FOR HUMAN IL-6 | |
| AR091703A1 (en) | ANTIBODIES AND IMMUNOCATE PLAYERS INCLUDING ANTI-CD22 ANTIBODIES | |
| NI200700315A (en) | ANTI-TRKB MONOCLONAL ANTIBODIES AND USES OF THE SAME. | |
| AR091961A1 (en) | IMMUNOCONJUGADOS AND ANTI-ETBR ANTIBODIES (ENDOTHELINE B RECEIVER) | |
| CY1119454T1 (en) | ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA | |
| ECSP045470A (en) | BIOLOGICAL PRODUCTS | |
| MX338754B (en) | HUMAN ANTIBODIES AGAINST TISSULAR FACTOR. | |
| CR11783A (en) | MOLECULA OF UNION TO THE ANTIGEN CAPAZ TO JOIN REPEATLY TO TWO OR MORE MOLECULES OF ANTIGEN | |
| AR074756A1 (en) | ANTIBODIES AGAINST HUMAN ANGIOPOYETINA-2 | |
| CY1115932T1 (en) | ANTIBODY PACKAGING | |
| ECSP088733A (en) | ANTI-5T4 ANTIBODIES AND USES OF THE SAME | |
| PE20140806A1 (en) | HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES | |
| AR096015A1 (en) | CONJUGATES OF DRUGS WITH ANTIBODIES | |
| CY1116842T1 (en) | SPECIFICALLY HUMANIZED ANTIBODIES IN THE PROTEINOLOGICAL FORM OF BETA-AMYLOID Peptide | |
| AR061538A1 (en) | ANTIBODY MOLECULES THAT JOIN THE HUMAN IL-17 | |
| AR095666A1 (en) | CONJUGATES OF DRUGS WITH ANTIBODIES | |
| UY32489A (en) | ANTIBODY MOLECULES THAT HAVE UNION SPECIFICITY FOR HUMAN IL-13 | |
| CL2018000131A1 (en) | Il22's immunoconjugates | |
| CO6390112A2 (en) | METHOD FOR THE TREATMENT OF PARKINSON'S DISEASE USING A FILAMENT BACTEROPHAGUS |